Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AstaReal USA Becomes First Qualified Producer of Natural Astaxanthin for Pet Supplementation
  • USA - English


News provided by

grapevine pr + consulting

Feb 23, 2017, 18:00 ET

Share this article

Share toX

Share this article

Share toX


Burlington, New Jersey (PRWEB) February 23, 2017 -- Today AstaReal USA announced its newly earned distinction as the Preferred Supplier of the National Animal Supplement Council (NASC). This makes AstaReal® the first qualified brand of natural astaxanthin for use in pet supplementation.

This recognition is a natural extension of what we stand for. - Arun Nair, CEO of AstaReal USA

Post this

Carefully grown and harvested in fully regulated indoor bioreactors in Moses Lake, Washington, U.S.A., AstaReal USA has earned this distinctive NASC Preferred Supplier Status for aligning with the Council’s mission of “Good Manufacturing Practice Quality Standards,” which includes precisely monitored and implemented quality control and strict label guidelines. AstaReal natural astaxanthin is non-GMO Project verified, suitable for vegetarians, and certified Kosher and Halal.    

Arun Nair, CEO of AstaReal USA, commented, “We are delighted to be part of a quality conscious manufacturers’ guild that commits to and practices the highest standards of safety and quality backed by science. This recognition is a natural extension of what we stand for. With AstaReal being the first and only preferred supplier of natural astaxanthin recognized by NASC, customers using AstaReal ingredients can be assured that product compliance for the safety of their companion animals is a top priority.”

Since 1994, AstaReal’s natural astaxanthin has been researched in over 140 published studies including 70 clinical trials. The results have shown that natural astaxanthin helps promote such areas as joint health¹, eye health², skin health³, cardiovascular health⁴, anti-fatigue⁵, general cognitive function⁶, sleep⁷, and muscle endurance⁸. The results have also shown parallel results with improvement in immune function⁹, endurance¹⁰, coat health¹¹, eye health¹², sleep¹³ and general well-being¹⁴ in companion animals. Now with its NASC Preferred Supplier status, AstaReal USA is able to introduce AstaReal natural astaxanthin’s superior health benefits to companion animals.

Astaxanthin is the most powerful naturally occurring antioxidant, shown to be 6,000 times more potent than Vitamin C and 800 times more potent than CoQ10 (Nishida Y. et al. Carotenoid Science, Vol.11, 2007, 16-20). Some antioxidants, like vitamin C, can exhibit prooxidant behavior in the presence of high concentrations of free radicals or redox-active metals (Carocho M. et al. Food and Chemical Toxicology 51 (2013) 15–25). Astaxanthin however does not exhibit prooxidant properties, making it a safer and healthier antioxidant option (Martin H.D. et al. J. Prakt. Chem. 1999 vol. 341(3): 302-308). Astaxanthin is one of the few carotenoids that can cross the blood-brain barrier and the blood-retinal barrier, adding a level of protection to the brain and eyes as well (Guerin M. et al. TRENDS in Biotechnology 2003 Vol.21(5): 210-216). Astaxanthin has also been shown to reduce levels of circulating C-Reactive Protein in the blood, which is a marker of systemic inflammation correlated with a risk for heart disease in humans (Park J.S. et al. 2010 Nutrition & Metabolism 2010, 7:18).

About NASC
The National Animal Supplement Council is a nonprofit trade organization dedicated to protecting and enhancing the health of companion animals and horses throughout the United States. Founded in 2001, NASC is an all-industry association of stakeholders concerned with the issues surrounding the supply of health supplements for animals not intended for human consumption, such as dogs, cats and horses. NASC members include manufacturers of the finest animal health supplements, who are committed to the highest standards of quality and safety in the industry today, as well as raw materials suppliers, distributors, veterinarians, retailers, pet professionals, and animal friends.

About AstaReal USA, Inc.
AstaReal USA, Inc. is part of AstaReal Holdings Co., Ltd., which is a wholly owned subsidiary of Fuji Chemical Group. AstaReal USA, Inc. is a natural astaxanthin manufacturer along with sales and marketing company servicing North and South America. AstaReal’s natural astaxanthin is cultivated, grown and harvested in its manufacturing facility in Moses Lake, Washington, U.S.A. As the global demand for natural astaxanthin continues to grow, AstaReal will continue to be fully dedicated to ensuring the consistent supply of premium, natural astaxanthin products.
*References

Human and Model Systems

joint health¹:
(Chen W.P. et al. International Immunopharmacology 19 (2014) 174–177; Huang L.J. et al. 2015 Modern Rheumatology 25(5):1-19; Maezawa T, et al. J Physiol Sci. 2016 Oct 6. [Epub ahead of print] PubMed PMID: 27714500)

eye health²:
Kajita et al. 2002 Journal of Traditional Medicines vol. 19(5):170-173
Nagaki et al. 2006; Journal of Clinical Therapeutics and Medicines vol. 22(1):41-54
Uchino Y. et al. 2012 The Journal of Nutrition, Health & Aging. Vol. 16(5): 478-481.            
Nakamura A et al., Jpn J Clin Opthalmol. 2004;58:1051-54.
Nitta T et al., J Clin Therap Med. 2005;21(5):534-56.
Nagaki Y et al., Folia Ophthalomogica Japonica. 2010;3(5):461-68.)

skin health³:
(Tominaga K et al., Acta Biochim Pol. 2012;59(1):43-7.
Suganuma K et al., 2012. Jichi Medical University Journal vol. 35:25-33.
Satoh A et al., Oyo Yakuri Pharmacometrics. 2011;80(1/2):7-11.
Tominaga K et al., Food Style 21. 2009;13(10):25-9.
Satoh A et al.,. Jpn J Environ Dermatol Cutan Allergol. 2009;3(5):429-38.
Yamashita E,Carotenoid Science. 2006;10:91-5.
Yamashita E, Food Style 21. 2002;6(6):112-7.
Seki T et al., Fragrance Journal. 2001;12:98-103.
Stahl W et al., Am J Clin Nutr. 000;71(3):795-8.
Camera E et al. Experimental Dermatology, 18, 222–231)

cardiovascular health⁴:
Yoshida H et al., Atherosclerosis. 2010;209(2):520-23.
lwabayashi M et al., Anti-aging medicine. 2009;6(4):15-21.
Miyawaki H et al., J Clin Biochem Nutr. 2008;43(2):69-74.
Hussein G et al., Biol Pharm Bull. 2005;28(6):967-71.
Kim KY et al., Nutritional Sciences. 2004;7(1):41-46.)

anti-fatigue⁵:
(Hongo N. et al. 2016. Journal of Clinical Therapeutics & Medicines

general cognitive function⁶:
Katagiri M. et al., J Clin Biochem Nutr. 2012;51(2):102-7.
Liu X. et al., Brain Res. Feb 13; 1254: 18-27.
Nakagawa K. et al. Br J Nutr. Jun;105(11): 1563-71.
Miyawaki H. et al. (2005). Journal of Clinical Therapeutics and Medicines., 21(4): 421-429.
Zanotta D. et al. (2014). Neuropsychiatr Dis Treat. Feb 3; 10:225-30.
Satoh A. et al. 2009 J. Clin. Biochem. Nutr., 44, 280–284.

sleep⁷:
Iwabayashi M. et al. 2009 ANTI-AGING MEDICINE, 2009, Vol.6(4), pp.15-21

muscle endurance⁸:
Park J.S. et al. J ANIM SCI 2013, 91:268-275.
Earnest CP et al. Int J sports Med. 2011;32:882-888
Finaud J, Lac G, Filaire E. Sports Med. 2006;36(4):327-358.
Tian Y et al. Eur J Appl Physiol . 2010;110:971- 976.
Semba RD, Lauretani F, Ferrucci L. 2007:15;458(2):141-145.
Berzosa C et al. Eur J Appl Physiol. 2010
Brzeszczynska J et al. Appl Physiol Nutr Metab. 2008;33(6):1223-1231.
Goto S et al. Biochim Biophysica Acta. 2001;1512:251-258.
Nishida Y, Yamashita E, Miki W. Carotenoid Science. 2007;11:16-20.
Miki W. Pure Appl Chem 1991;1(63):141-146.
Martin HD et al. Pure Appl Chem 1999;71(12):2253-2262.
Malmsten CL, Lignell Å. Carotenoid Science. 2008;13.
Sawaki K et al. Journal of Clinical Therapeutics&Medicine. 2002;18(9);73-88.
Ikeuchi M, Koyama T, Takahashu J, Yazawa K. Biol Phram Bull. 2006;29(10)2106-2110.
Aoi W et al. Biochem Biophys Res Commun. 2008; 366(4):892-897.
Fukamauchi M. Food Style 21. 2007;11:1-4. 15.
Ikeuchi M et al. The 21st Annual Meeting on Carotenoid Research 2007.
Nakagawa K et al. Br J Nutr. 2011;31:1-9.
Wolf AM et al. J Nutr Biochem. 2010;21(5):381-389
Aoi W et al. Antioxid Redox Signal. 2003;5(1):139-144.
Park JS et al. Nutrition & Metabolism. 2010;7:18.
Lee SJ et al. Mol Cells. 2003;16(1):97-105.
Shibaguchi T et al. Jpn J Phys Fitness Sports

Companion Animals

immune function⁹:
Chew B.P. et al. 2011 Veterinary Immunology and Immunopathology, 15 April 2011, Vol.140(3-4), pp.199-206

endurance¹⁰:
Zanghi BM 2015 _Am J Vet Res. 76(4)338-50

coat health¹¹:
Park J. et al. 2010 Nutrition & Metabolism, Vol.7(1), p.52

eye health¹²:
Wang W. et al. Journal of Nutritional Science (2016), vol. 5, e18, page 1-7

sleep¹³
Honda, T. et al. 2007 Astaxanthin-containing pet foods. USPTO # US 2007/0128310 Al. https://www.google.com/patents/US20070128310.

general well-being¹⁴:
Park, J.S. et al. 2014. J. Anim. Sci. 2013.91:268–275
Gross G.J. et al. 2005 Molecular and Cellular Biochemistry 272: 221–227

Steven Le Vine, grapevine pr + consulting, http://www.theprgrapevine.com, +1 (323) 386-2300 Ext: 1, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.